AIDS group suing Tibotec for overcharging in safety-net suit
This article was originally published in Scrip
Executive Summary
The AIDS Healthcare Foundation (AHF) is suing Tibotec Therapeutics, a Johnson & Johnson company, for overcharging the group for drugs to treat HIV/AIDS purchased under the US government’s 340B pricing programme. This programme requires manufacturers to enter into agreements to provide outpatient medicines to safety-net providers and other qualifying entities at reduced prices.